Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000820912 | SCV000961649 | uncertain significance | Spermatogenic failure 18; Ciliary dyskinesia, primary, 37 | 2022-03-13 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). ClinVar contains an entry for this variant (Variation ID: 663109). This variant has not been reported in the literature in individuals affected with DNAH1-related conditions. This variant is present in population databases (rs761794737, gnomAD 0.007%). This sequence change replaces tyrosine, which is neutral and polar, with cysteine, which is neutral and slightly polar, at codon 2978 of the DNAH1 protein (p.Tyr2978Cys). |
Ambry Genetics | RCV002537481 | SCV003745879 | uncertain significance | Inborn genetic diseases | 2022-07-20 | criteria provided, single submitter | clinical testing | The c.8933A>G (p.Y2978C) alteration is located in exon 56 (coding exon 55) of the DNAH1 gene. This alteration results from a A to G substitution at nucleotide position 8933, causing the tyrosine (Y) at amino acid position 2978 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |